Stewart, A Keith <br/><br/>
Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Dec 2004 
 - 8170-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-04-1106  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Combined Modality Therapy<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Middle Aged<br/>Multiple Myeloma--therapy<br/>Prednisone--administration & dosage<br/>Stem Cell Transplantation<br/>Survival Rate<br/>Thalidomide--administration & dosage<br/>Transplantation, Autologous<br/>Treatment Outcome